Advancing systematic-review methodology in exposure science for environmental health decision making.

Environmental health Exposure assessment Research synthesis Risk assessment Study design Systematic review

Journal

Journal of exposure science & environmental epidemiology
ISSN: 1559-064X
Titre abrégé: J Expo Sci Environ Epidemiol
Pays: United States
ID NLM: 101262796

Informations de publication

Date de publication:
11 2020
Historique:
received: 02 03 2020
accepted: 15 05 2020
revised: 06 05 2020
pubmed: 30 5 2020
medline: 29 12 2020
entrez: 30 5 2020
Statut: ppublish

Résumé

Systematic review (SR) is a rigorous methodology applied to synthesize and evaluate a body of scientific evidence to answer a research or policy question. Effective use of systematic-review methodology enables use of research evidence by decision makers. In addition, as reliance on systematic reviews increases, the required standards for quality of evidence enhances the policy relevance of research. Authoritative guidance has been developed for use of SR to evaluate evidence in the fields of medicine, social science, environmental epidemiology, toxicology, as well as ecology and evolutionary biology. In these fields, SR is typically used to evaluate a cause-effect relationship, such as the effect of an intervention, procedure, therapy, or exposure on an outcome. However, SR is emerging to be a useful methodology to transparently review and integrate evidence for a wider range of scientifically informed decisions and actions across disciplines. As SR is being used more broadly, there is growing consensus for developing resources, guidelines, ontologies, and technology to make SR more efficient and transparent, especially for handling large amounts of diverse data being generated across multiple scientific disciplines. In this article, we advocate for advancing SR methodology as a best practice in the field of exposure science to synthesize exposure evidence and enhance the value of exposure studies. We discuss available standards and tools that can be applied and extended by exposure scientists and highlight early examples of SRs being developed to address exposure research questions. Finally, we invite the exposure science community to engage in further development of standards and guidance to grow application of SR in this field and expand the opportunities for exposure science to inform environment and public health decision making.

Identifiants

pubmed: 32467626
doi: 10.1038/s41370-020-0236-0
pii: 10.1038/s41370-020-0236-0
pmc: PMC8215717
mid: NIHMS1710491
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

906-916

Subventions

Organisme : Intramural EPA
ID : EPA999999
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

J R Soc Med. 2015 Jun;108(6):237-41
pubmed: 26085561
Environ Int. 2018 Dec;121(Pt 1):1027-1031
pubmed: 30166065
Environ Int. 2019 Sep;130:104871
pubmed: 31254867
Environ Health Perspect. 2017 Feb;125(2):155-162
pubmed: 27385285
BMJ Evid Based Med. 2018 Aug;23(4):121-122
pubmed: 29921711
Appl In Vitro Toxicol. 2017 Dec 01;3(4):298-311
pubmed: 30057931
Environ Sci Technol. 2012 Mar 20;46(6):3046-53
pubmed: 22324457
Environ Health Perspect. 2017 Mar;125(3):296-305
pubmed: 27458779
Environ Int. 2019 Nov;132:104768
pubmed: 31196577
Environ Health Perspect. 2014 Oct;122(10):1007-14
pubmed: 24968373
Curr Environ Health Rep. 2018 Jun;5(2):213-224
pubmed: 29737463
Environ Int. 2016 Jul-Aug;92-93:556-64
pubmed: 26687863
Am J Ind Med. 2017 Feb;60(2):189-197
pubmed: 28079279
Sci Total Environ. 2020 Apr 10;712:136263
pubmed: 32050401
J Rheumatol. 2011 Apr;38(4):598-605
pubmed: 21239751
Environ Int. 2018 Oct;119:174-185
pubmed: 29958118
Sci Total Environ. 2019 Dec 1;694:133489
pubmed: 31756826
Syst Rev. 2012 Feb 09;1:7
pubmed: 22588008
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W541-5
pubmed: 21672956
Environ Int. 2019 Feb;123:209-223
pubmed: 30530163
Health Info Libr J. 2009 Jun;26(2):91-108
pubmed: 19490148
Am J Epidemiol. 2019 Sep 1;188(9):1581-1585
pubmed: 31145434
Syst Rev. 2016 May 23;5:87
pubmed: 27216467
Nutr Rev. 2010 Feb;68(2):114-21
pubmed: 20137056
Environ Int. 2016 Jul-Aug;92-93:578-84
pubmed: 26371438
Environ Health Perspect. 2013 Apr;121(4):A108-9
pubmed: 23548834
Arch Pediatr Adolesc Med. 2007 Jan;161(1):78-88
pubmed: 17199071

Auteurs

Elaine A Cohen Hubal (EA)

Office of Research and Development, US Environmental Protection Agency, Durham, NC, USA. Hubal.elaine@epa.gov.

Jessica J Frank (JJ)

Tetra Tech Inc, Fairfax, VA, USA.

Rebecca Nachman (R)

Office of Research and Development, US Environmental Protection Agency, Durham, NC, USA.

Michelle Angrish (M)

Office of Research and Development, US Environmental Protection Agency, Durham, NC, USA.

Nicole C Deziel (NC)

Environmental Health Sciences, Yale University School of Public Health, New Haven, CT, USA.

Meridith Fry (M)

Office of Research and Development, US Environmental Protection Agency, Durham, NC, USA.

Rogelio Tornero-Velez (R)

Office of Research and Development, US Environmental Protection Agency, Durham, NC, USA.

Andrew Kraft (A)

Office of Research and Development, US Environmental Protection Agency, Durham, NC, USA.

Emma Lavoie (E)

Office of Research and Development, US Environmental Protection Agency, Durham, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH